Takeda delivers solid first quarter fy2021 results, positioning company to accelerate topline growth and continued pipeline progress

Osaka, japan--(business wire)--takeda pharmaceutical company limited (tokyo:4502/nyse:tak) (“takeda”) today announced financial results for the first quarter of fiscal year 2021 (period ended june 30, 2021). based on the solid first-quarter results, the company also confirmed its fiscal year 2021 management guidance and forecast. fiscal year 2021 remains a year of inflection with takeda positioned for topline acceleration and continued pipeline progress, including critical regulatory submission
TAK Ratings Summary
TAK Quant Ranking